PL2072053T3 - Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium - Google Patents

Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium

Info

Publication number
PL2072053T3
PL2072053T3 PL07301736T PL07301736T PL2072053T3 PL 2072053 T3 PL2072053 T3 PL 2072053T3 PL 07301736 T PL07301736 T PL 07301736T PL 07301736 T PL07301736 T PL 07301736T PL 2072053 T3 PL2072053 T3 PL 2072053T3
Authority
PL
Poland
Prior art keywords
administering
abdominal girth
bifidobacterium bacteria
decreasing abdominal
decreasing
Prior art date
Application number
PL07301736T
Other languages
English (en)
Inventor
Nathalie Goupil-Feuillerat
Denis Guyonnet
Stefan Jakob
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39327067&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2072053(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of PL2072053T3 publication Critical patent/PL2072053T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL07301736T 2007-12-21 2007-12-21 Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium PL2072053T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07301736A EP2072053B1 (en) 2007-12-21 2007-12-21 Method for decreasing abdominal girth by administering a bifidobacterium bacteria

Publications (1)

Publication Number Publication Date
PL2072053T3 true PL2072053T3 (pl) 2013-02-28

Family

ID=39327067

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07301736T PL2072053T3 (pl) 2007-12-21 2007-12-21 Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium

Country Status (10)

Country Link
US (1) US20100303763A1 (pl)
EP (2) EP2072053B1 (pl)
JP (2) JP2011507496A (pl)
KR (2) KR20100102178A (pl)
CN (1) CN101977614A (pl)
AR (1) AR069943A1 (pl)
ES (1) ES2395838T3 (pl)
PL (1) PL2072053T3 (pl)
RU (1) RU2491946C2 (pl)
WO (1) WO2009080800A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3121192B2 (ja) 1993-12-27 2000-12-25 信越化学工業株式会社 酸化物単結晶の製造方法
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
WO2011051760A1 (en) * 2009-11-02 2011-05-05 Compagnie Gervais Danone Method for reducing gastro-intestinal inflammation using bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteria
WO2011148220A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving transepithelial resistance
WO2011148219A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
EP2651423B1 (en) 2010-12-17 2015-09-30 Compagnie Gervais Danone Lactococcus lactis strains for use in improving digestive condition
EP2925162A1 (en) * 2012-11-29 2015-10-07 Nestec S.A. Synbiotic composition and use thereof
BR112016018283A2 (pt) * 2014-02-14 2017-08-08 Vesale Pharma Sa Composição que compreende bifidobacterium animalis ssp. lactis
RU2613125C1 (ru) * 2016-04-11 2017-03-15 Оксана Владимировна Крапивная Способ лечения синдрома раздраженного кишечника с запором, ассоциированного синдромом избыточного бактериального роста
RU2644634C1 (ru) * 2017-03-07 2018-02-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Способ лечения больных с клиническими проявлениями синдрома раздраженного кишечника
US10376200B2 (en) * 2017-09-28 2019-08-13 Hong Min Kim System for detecting and logging of flatulence for health indication

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
FR2808689B1 (fr) 2000-05-11 2004-09-03 Agronomique Inst Nat Rech Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
FR2811333B1 (fr) * 2000-07-04 2003-01-10 Gervais Danone Sa Microorganismes ayant une action modulatrice de la glycosylation de surface des cellules intestinales et methode de selection desdits microorganismes
RU2223774C2 (ru) * 2002-04-11 2004-02-20 Закрытое акционерное общество "Партнер" Способ коррекции дисбиотических расстройств у детей раннего возраста с диареями
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
RU2291194C2 (ru) * 2003-03-17 2007-01-10 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" Консорциум штаммов бифидобактерий, используемый для получения жидкого концентрата бифидобактерий, кисломолочных, неферментированных лечебно-профилактических продуктов, биологически активных добавок и бактерийных препаратов
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
DK1931363T3 (en) * 2005-09-28 2016-02-22 Nordisk Rebalance As Treatment of IBD using both probiotic bacteria and fermented cereal as behandlingseffektorer

Also Published As

Publication number Publication date
RU2010130299A (ru) 2012-01-27
RU2491946C2 (ru) 2013-09-10
JP2014065743A (ja) 2014-04-17
EP2072053B1 (en) 2012-11-07
KR20100102178A (ko) 2010-09-20
ES2395838T3 (es) 2013-02-15
WO2009080800A2 (en) 2009-07-02
KR20160011234A (ko) 2016-01-29
EP2224935A2 (en) 2010-09-08
JP5850956B2 (ja) 2016-02-03
WO2009080800A3 (en) 2010-04-22
EP2072053A1 (en) 2009-06-24
US20100303763A1 (en) 2010-12-02
CN101977614A (zh) 2011-02-16
AR069943A1 (es) 2010-03-03
JP2011507496A (ja) 2011-03-10

Similar Documents

Publication Publication Date Title
WO2011053806A9 (en) Adjustable saddle for a bone anchor
PL2496241T3 (pl) Sposoby zmniejszania stanu zapalnego przewodu pokarmowego z zastosowaniem bakterii Bifidobacterium animalis albo fermentowanego produktu nabiałowego obejmującego takie bakterie
IL197474A0 (en) Long-term enteral feed for maintenance
PL2220377T3 (pl) Urządzenie zaworowe
IL210393A0 (en) Administration regime for nitrocatechols
GB0715637D0 (en) Manifold apparatus
GB0718245D0 (en) Bioreactors for tissue engineering
ZA201000733B (en) System for producing microorganisms
ZA201008841B (en) 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
IL195651A0 (en) Reinforced enteral feeding catheter
GB0815866D0 (en) Abdominal exercise apparatus
PL2300024T3 (pl) Sposób zmniejszania burczenia brzucha przez podawanie bakterii Bifidobacterium
IL211922A0 (en) Method for producing a bulk concentrate
IL187286A0 (en) A feeding apparatus
ZA200907537B (en) A method for the preparation of mirtazapine
EP2171578A4 (en) MODEL PROGRAMMING FOR MODULAR DEVELOPMENT
GB0800752D0 (en) Apparatus for a hive
GB0722274D0 (en) New therapeutic method
GB0721472D0 (en) Apparatus for a hive
GB2474564B (en) A training apparatus
TWI317791B (en) Valve apparatus
GB0918936D0 (en) Catalytic feeding trainer
GB0719406D0 (en) A patient manoeuving system
GB0612695D0 (en) Process for preparing a solid dosage form
IL216503A0 (en) Method for purifying a pyrazolinone derivative